DK135711B - Analogifremgangsmåde til fremstilling af hidtil ukendte, hjerteaktive substituerede fenoxyisopropanolaminer. - Google Patents

Analogifremgangsmåde til fremstilling af hidtil ukendte, hjerteaktive substituerede fenoxyisopropanolaminer.

Info

Publication number
DK135711B
DK135711B DK53975AA DK53975A DK135711B DK 135711 B DK135711 B DK 135711B DK 53975A A DK53975A A DK 53975AA DK 53975 A DK53975 A DK 53975A DK 135711 B DK135711 B DK 135711B
Authority
DK
Denmark
Prior art keywords
phenoxyisopropanolamines
preparation
analogous process
active substituted
novel cardiac
Prior art date
Application number
DK53975AA
Other languages
Danish (da)
English (en)
Other versions
DK53975A (de
DK135711C (de
Inventor
Enar Ingemar Carlsson
Nils Henry Alfons Persson
Gustav Benny Samuelsson
Kjell Ingvar Leopold Wetterlin
Original Assignee
Haessle Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haessle Ab filed Critical Haessle Ab
Publication of DK53975A publication Critical patent/DK53975A/da
Publication of DK135711B publication Critical patent/DK135711B/da
Application granted granted Critical
Publication of DK135711C publication Critical patent/DK135711C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/52—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups or amino groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/28—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
    • C07C217/30—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/32—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/28—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
    • C07C217/30—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/32—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
    • C07C217/34—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by halogen atoms, by trihalomethyl, nitro or nitroso groups, or by singly-bound oxygen atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
DK53975AA 1974-02-14 1975-02-14 Analogifremgangsmåde til fremstilling af hidtil ukendte, hjerteaktive substituerede fenoxyisopropanolaminer. DK135711B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7401958A SE388849B (sv) 1974-02-14 1974-02-14 Forfarande for framstellning av nya aminer med beta-receptorstimulerande verkan

Publications (3)

Publication Number Publication Date
DK53975A DK53975A (de) 1975-10-06
DK135711B true DK135711B (da) 1977-06-13
DK135711C DK135711C (de) 1977-11-21

Family

ID=20320208

Family Applications (1)

Application Number Title Priority Date Filing Date
DK53975AA DK135711B (da) 1974-02-14 1975-02-14 Analogifremgangsmåde til fremstilling af hidtil ukendte, hjerteaktive substituerede fenoxyisopropanolaminer.

Country Status (23)

Country Link
US (2) US4244969A (de)
JP (1) JPS50116433A (de)
AT (1) AT334881B (de)
AU (1) AU497441B2 (de)
BE (1) BE825515A (de)
CA (1) CA1052387A (de)
CH (1) CH616648A5 (de)
CS (2) CS202035B2 (de)
DD (1) DD118614A5 (de)
DE (1) DE2502993A1 (de)
DK (1) DK135711B (de)
FI (1) FI62055B (de)
FR (1) FR2261000B1 (de)
GB (1) GB1492647A (de)
HU (1) HU169704B (de)
IE (1) IE41350B1 (de)
IT (1) IT7950875A0 (de)
LU (1) LU71846A1 (de)
NL (1) NL7501785A (de)
NO (1) NO140628C (de)
SE (1) SE388849B (de)
SU (3) SU603332A3 (de)
ZA (1) ZA75381B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4210653A (en) * 1978-06-27 1980-07-01 Merck & Co., Inc. Pyridyloxypropanolamines
SE8004088L (sv) * 1980-06-02 1981-12-03 Haessle Ab Nya substituerade 3-fenoxi-l-alkoxikarbonylalkylamino-propanol-2-er med beta-receptorblockerande egenskaper samt forfarande for deras framstellning, farmaceutiska beredningar innehallande desamma och metod att ...
US4396629A (en) * 1980-12-29 1983-08-02 Sterling Drug Inc. Compositions, processes and method
US5166218A (en) * 1983-10-19 1992-11-24 Hoffmann-La Roche Inc. Phenoxypropanolamines and pharmaceutical compositions thereof
CA1262729A (en) * 1983-10-19 1989-11-07 Leo Alig Phenoxypropanolamines
SE457505B (sv) * 1984-01-10 1989-01-09 Lejus Medical Ab Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning
DE3544172A1 (de) * 1985-12-13 1987-06-19 Lentia Gmbh Neue kristalline salze von aryloxy-propanolaminen, verfahren zu ihrer herstellung und ihre verwendung
EP0283540B1 (de) * 1987-03-26 1991-09-18 Helopharm W. Petrik GmbH & Co.KG. Verfahren zur Herstellung von 5-Hydroxydiprafenon und seiner Salze mit Säuren
SG99290A1 (en) * 1996-04-09 2003-10-27 Nps Pharma Inc Calcilytic compounds
US6818660B2 (en) 1996-04-09 2004-11-16 Nps Pharmaceuticals, Inc. Calcilytic compounds
US5966498A (en) * 1996-08-07 1999-10-12 Lakewood Engineering And Manufacturing Company End closure assembly for oil-filled heater
TW483881B (en) 1996-12-03 2002-04-21 Nps Pharma Inc Calcilytic compounds
US7202261B2 (en) 1996-12-03 2007-04-10 Nps Pharmaceuticals, Inc. Calcilytic compounds
JP4604583B2 (ja) * 2004-07-20 2011-01-05 ダイソー株式会社 １−アミド−３−（２−ヒドロキシフェノキシ）−２−プロパノール誘導体、ならびに２−アミドメチル−１，４−ベンゾジオキサン誘導体の製造法
IL165365A0 (en) 2004-11-24 2006-01-15 Q Core Ltd Finger-type peristaltic pump
JP4934287B2 (ja) * 2005-04-05 2012-05-16 花王株式会社 美白剤
FR2916441B1 (fr) * 2007-05-22 2009-08-28 Clariant Specialty Fine Chem Procede de racemisation d'alpha-aminoacetals optiquement actifs.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL301580A (de) * 1962-12-11
GB1069345A (en) * 1963-07-19 1967-05-17 Ici Ltd New alkanolamine derivatives
DE1922003C3 (de) * 1969-04-30 1979-10-11 Boehringer Mannheim Gmbh, 6800 Mannheim N-(3-Aryloxy-2-hydroxypropyl)-aminocarbonsäuren, deren Ester, Amide und Salze, Verfahren zur Herstellung dieser Verbindungen und deren Verwendung bei der Bekämpfung von Herzinsuffizienz
BE790165A (fr) * 1971-12-14 1973-02-15 Parke Davis & Co Nouveaux aminoalcanols et procede pour les preparer

Also Published As

Publication number Publication date
CS202035B2 (en) 1980-12-31
JPS50116433A (de) 1975-09-11
AU497441B2 (en) 1978-12-14
IE41350B1 (en) 1979-12-19
NO750468L (de) 1975-08-15
DK53975A (de) 1975-10-06
IT7950875A0 (it) 1979-11-21
CH616648A5 (de) 1980-04-15
HU169704B (de) 1977-02-28
SE7401958L (de) 1975-08-15
IE41350L (en) 1975-08-14
CA1052387A (en) 1979-04-10
FR2261000B1 (de) 1978-07-21
AU7811675A (en) 1976-08-12
BE825515A (fr) 1975-08-14
FR2261000A1 (de) 1975-09-12
AT334881B (de) 1977-02-10
NO140628C (no) 1979-10-10
GB1492647A (en) 1977-11-23
LU71846A1 (de) 1975-12-09
SE388849B (sv) 1976-10-18
FI750390A (de) 1975-08-15
ATA96475A (de) 1976-06-15
DE2502993A1 (de) 1975-09-04
NL7501785A (nl) 1975-08-18
ZA75381B (en) 1976-01-28
US4244969A (en) 1981-01-13
SU609460A3 (ru) 1978-05-30
DK135711C (de) 1977-11-21
US4336267A (en) 1982-06-22
FI62055B (fi) 1982-07-30
SU577971A3 (ru) 1977-10-25
CS202036B2 (en) 1980-12-31
SU603332A3 (ru) 1978-04-15
DD118614A5 (de) 1976-03-12
NO140628B (no) 1979-07-02

Similar Documents

Publication Publication Date Title
DK136718B (da) Analogifremgangsmåde til fremstilling af substituerede hexahydro-dibenzo(b,d)-pyran-9-oner.
DK136719B (da) Analogifremgangsmåde til fremstilling af substituerede hexahydro-dibenzo(b,d)-pyraner.
DK136075B (da) Analogifremgangsmåde til fremstilling af 11beta-hydroxy-16-methyl-3-oxo-17alfa-acyloxyandrosta-1,4,15-trien-17beta-carboxylater.
DK135711B (da) Analogifremgangsmåde til fremstilling af hidtil ukendte, hjerteaktive substituerede fenoxyisopropanolaminer.
DK137835B (da) Analogifremgangsmåde til fremstilling af thienothiazinderivater.
DK139678B (da) Fremgangsmåde til fremstilling af 2,2,6,6-tetramethyl-4-oxopiperidin.
DK139846B (da) Analogifremgangsmåde til fremstilling af 3-alkoxypyrazin-2-carboxamider.
DK135796B (da) Fremgangsmåde til fremstilling af alkyl-tert-alkylethere.
DK138321B (da) Analogifremgangsmåde til fremstilling af 5-halogen-2,3-kresotinsyrederivater.
DK140406B (da) Fremgangsmåde til fremstilling af 2,2,6,6-tetramethyl-4-oxopiperidin.
DK137389B (da) Analogifremgangsmåde til fremstilling af 11beta-substituerede delta4-østrener.
DK136529B (da) Analogifremgangsmåde til fremstilling af benzofuranderivater.
DK135723B (da) Analogifremgangsmåde til fremstilling af 7alfa-acylthio-3-oxo-D-homo-21,24-dinor-17aalfa-chlo-4-en-23,17a-lactoner.
DK132328B (da) Analogifremgangsmåde til fremstilling af 17beta-hydroxy-16,16-dimethylestr-4-en-3-on.
DK139682B (da) Analogifremgangsmåde til fremstilling af eburnameninderivater.
DK135167B (da) Analogifremgangsmåde til fremstilling af 7,7'-ditheophyllinderivater.
DK137043B (da) Analogifremgangsmåde til fremstilling af nitrocarbostyrilforbindelser.
DK137449B (da) Fremgangsmåde til fremstilling af N,N-diallyldichloracetamid.
DK137646B (da) Fremgangsmåde til fremstilling af 6-chlor-2-chlormethyl-4-phenylquinazolin-3-oxid.
DK138694B (da) Fremgangsmåde til fremstilling af phenylphosphonothiodichlorid.
DK140670B (da) Analogifremgangsmåde til fremstilling af ergopeptinderivater.
DK138499B (da) Fremgangsmåde til fremstilling af 11beta-hydroksy-18-alkyløstranforbindelser.
DK136619B (da) Fremgangsmåde til fremstilling af dihydrokanadensolid.
DK136652B (da) Fremgangsmåde til fremstilling af thieno-pyridinderivater.
DK140313B (da) Analogifremgangsmåde til fremstilling af 1-sulfonyl-5(6)-substitueret-benzimidazoler.